UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
January 7, 2026 4:30 P.M.
Form:
F-10
CIK:
0001751912
Company Name:
NERVGEN PHARMA CORP.
File Number:
333-292197